Incomplete Kawasaki disease presenting primarily with cough: a case report and brief literature review
- PMID: 40830770
- PMCID: PMC12366090
- DOI: 10.1186/s12887-025-05957-2
Incomplete Kawasaki disease presenting primarily with cough: a case report and brief literature review
Abstract
Background: Kawasaki disease (KD) is an acute systemic vasculitis predominantly affecting children under 5 years of age. To prevent the development of cardiac aneurysms and their associated adverse outcomes, such as coronary artery dissection with subsequent bleeding, early recognition and treatment are of utmost importance. The classic early symptoms of KD include fever, conjunctival congestion, cracked lips, and others. However, these symptoms are not exclusive to KD and can also be observed in a variety of infectious diseases. Peeling of the skin on the hands, feet, fingers, and around the anus typically becomes evident around ten days after the onset of the disease or even later. Once complications occur, treatment may be ineffective. Hence, early diagnosis and timely treatment are essential to control disease progression, prevent further exacerbation of complications, and promote rapid lesion recovery.
Case presentation: A 3-year-old boy initially presented solely with sever cough symptoms, followed by fever, which are typical manifestations of a respiratory illness. Additionally, conjunctival hemorrhage developed during the course of the illness. Laboratory tests showed significant elevation in erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Despite anti-infective treatment with ceftriaxone, the condition did not improve. The clinical presentation and laboratory findings were consistent with a diagnosis of incomplete Kawasaki disease (IKD). Immediately after treatment with intravenous immunoglobulin (IVIG) and aspirin, the patient's fever and cough symptoms subsided within the next two days. Cardiac ultrasonography at the time of discharge indicated that the coronary artery had healed. At the 1-month and 3-month follow-ups, the patient was in good general health.
Conclusions: It is uncommon for a patient with Kawasaki disease (KD) to initially present with a severe cough as the predominant symptom, especially in the absence of other classic clinical features and with poor response to anti-infective therapy. Therefore, in such cases, clinicians should maintain a high index of suspicion for incomplete Kawasaki disease (IKD) and promptly conduct coronary artery evaluations to avoid delays in diagnosis and treatment.
Keywords: Case report; Cough; Diagnosis; Incomplete Kawasaki disease; Kawasaki disease.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Written informed consent was obtained from patient’s parents for the participation. All methods were performed in accordance with the relevant guidelines and regulations. Consent for publication: Written informed consent was obtained from the patient’s parents for publication of this case report and any accompanying images. A copy of the written consent is available for review. Competing interests: The authors declare no competing interests.
Figures


Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Corticosteroids for the treatment of Kawasaki disease in children.Cochrane Database Syst Rev. 2017 Jan 27;1(1):CD011188. doi: 10.1002/14651858.CD011188.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2022 May 27;5:CD011188. doi: 10.1002/14651858.CD011188.pub3. PMID: 28129459 Free PMC article. Updated.
-
Intravenous immunoglobulin for the treatment of Kawasaki disease.Cochrane Database Syst Rev. 2023 Jan 25;1(1):CD014884. doi: 10.1002/14651858.CD014884.pub2. Cochrane Database Syst Rev. 2023. PMID: 36695415 Free PMC article.
-
Ophthalmia Neonatorum.2025 Jul 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31855399 Free Books & Documents.
-
[Guidelines for the prevention and management of bronchial asthma (2024 edition)].Zhonghua Jie He He Hu Xi Za Zhi. 2025 Mar 12;48(3):208-248. doi: 10.3760/cma.j.cn112147-20241013-00601. Zhonghua Jie He He Hu Xi Za Zhi. 2025. PMID: 40050074 Chinese.
References
-
- McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135:e927–99. - PubMed
-
- Kobayashi T, Ayusawa M, Suzuki H, et al. Revision of diagnostic guidelines for Kawasaki disease (6th revised edition). Pediatr Int. 2020;62(10):1135–8. - PubMed
-
- Shi H, Qiu H, Jin Z, Li C, Yang X, Huang C, et al. Coronary artery lesion risk and mediating mechanism in children with complete and incomplete Kawasaki disease. J Investig Med. 2019;67:950–6. - PubMed
-
- Sudo D, Monobe Y, Yashiro M, Mieno MN, Uehara R, Tsuchiya K, et al. Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan. Eur J Pediatr. 2012;171:651–6. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous